Gene · 4277
Papers3,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Plasma proteins and onset of type 2 diabetes and diabetic complications: Proteome-wide Mendelian randomization and colocalization analyses. | Cell Rep Med | 2023 | 37652020 | PubTator, text mining | PubMed |
| Decision trees to evaluate the risk of developing multiple sclerosis. | Front Neuroinform | 2023 | 37649987 | PubTator, text mining | PubMed |
| Natural killer cells in tumor immunotherapy. | Cancer Biol Med | 2023 | 37646229 | PubTator, text mining | PubMed |
| CAR-T cells dual-target CD123 and NKG2DLs to eradicate AML cells and selectively target immunosuppressive cells. | Oncoimmunology | 2023 | 37645216 | PubTator, text mining | PubMed |
| Lipid metabolic vulnerabilities of multiple myeloma. | Clin Exp Med | 2023 | 37639069 | PubTator, text mining | PubMed |
| The complex HLA-E-nonapeptide in Behçet disease. | Front Immunol | 2023 | 37638008 | PubTator, text mining | PubMed |
| Spatially Resolved Transcriptomics Technology Facilitates Cancer Research. | Adv Sci (Weinh) | 2023 | 37632718 | PubTator, text mining | PubMed |
| Targeting Melanoma-Associated Fibroblasts (MAFs) with Activated γδ (Vδ2) T Cells: An In Vitro Cytotoxicity Model. | Int J Mol Sci | 2023 | 37629075 | PubTator, text mining | PubMed |
| Crosstalk of Mast Cells and Natural Killer Cells with Neurons in Chemotherapy-Induced Peripheral Neuropathy. | Int J Mol Sci | 2023 | 37628724 | PubTator, text mining | PubMed |
| The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer. | Biology (Basel) | 2023 | 37626965 | PubTator, text mining | PubMed |
| Current approaches to develop "off-the-shelf" chimeric antigen receptor (CAR)-T cells for cancer treatment: a systematic review. | Exp Hematol Oncol | 2023 | 37605218 | PubTator, text mining | PubMed |
| NKG2D promotes CD8 T cell-mediated cytotoxicity and is associated with treatment failure in human cutaneous leishmaniasis. | PLoS Negl Trop Dis | 2023 | 37603573 | PubTator, text mining | PubMed |
| Classification and function of γδT cells and its research progress in anti-glioblastoma. | Discov Oncol | 2023 | 37597083 | PubTator, text mining | PubMed |
| Fluid shear stress enhances natural killer cell's cytotoxicity toward circulating tumor cells through NKG2D-mediated mechanosensing. | APL Bioeng | 2023 | 37575881 | PubTator, text mining | PubMed |
| Involvement of KLRK1 in immune infiltration of head and neck squamous cell carcinoma correlates with favorable prognosis. | Medicine (Baltimore) | 2023 | 37565867 | PubTator, text mining | PubMed |
| ADAM17 targeting by human cytomegalovirus remodels the cell surface proteome to simultaneously regulate multiple immune pathways. | Proc Natl Acad Sci U S A | 2023 | 37561786 | PubTator, text mining | PubMed |
| The yes-associated protein (YAP) is associated with resistance to anti-GD2 immunotherapy in neuroblastoma through downregulation of ST8SIA1. | Oncoimmunology | 2023 | 37554309 | PubTator, text mining | PubMed |
| Regulatory mechanisms and therapeutic implications of insulin-like growth factor 2 mRNA-binding proteins, the emerging crucial m6A regulators of tumors. | Theranostics | 2023 | 37554271 | PubTator, text mining | PubMed |
| Immune gene signatures as prognostic criteria for cancer patients. | Ther Adv Med Oncol | 2023 | 37547445 | PubTator, text mining | PubMed |
| Natural killer cell-derived exosomes for cancer immunotherapy: innovative therapeutics art. | Cancer Cell Int | 2023 | 37543612 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4277/papers?page=16